Navigation Links
Neurocrine Biosciences Reports First Quarter 2008 Results
Date:4/30/2008

ations (20,762) (27,274)

Other income and (expenses):

Interest income and other income 1,606 2,424

Interest expense (1,921) (870)

Total other income (315) 1,554

Net loss $(21,077) $(25,720)

Net loss per common share:

Basic and Diluted $(0.55) $(0.68)

Shares used in the calculation of net loss per

common share:

Basic and Diluted 38,330 37,908

NEUROCRINE BIOSCIENCES, INC.

Condensed Consolidated Balance Sheets

(in thousands)

March 31, December 31,

2008 2007

(unaudited)

Cash, cash equivalents and marketable securities $149,745 $179,385

Other current assets 2,458 3,563

Total current assets 152,203 182,948

Property and equipment, net 80,672 82,598

Restricted cash 6,415 6,399

Other non-current assets 4,594 4,709

Total assets $243,884 $276,654

Current liabilities $17,972 $29,907

Long-term liabilities 127,246 128,050

Stockholders' equity 98,666 118,697

Total liabilities and stockholders' equity $243,884 $276,654


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
3. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
4. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
5. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
6. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
7. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Calif. and STATE COLLEGE, Pa., Dec. 3 /PRNewswire...ed the signing of an agreement to provide extended...cs, NextGENe software for next-generation sequenci...ttp://www.newscom.com/cgi-bin/prnh/20090428/LA0674...id, "Our team at Ambry has been providing genomics...
(Date:12/3/2009)...alif., Dec. 3 Pharmacycl...mpany focused on developing and commercializing in... immune mediated diseases and cancer, today announ...l on, Tuesday, December 8, 2009 at 11:00am Eastern...e) to discuss clinical data regarding its HDAC Pro...
(Date:12/3/2009)...c. 3 BioMed Realty Trust...entered into a new lease with Regeneron Pharmaceut...,000 square feet of additional, newly-constructed ...tview campus in Tarrytown, New York. The new lease...l space was completed approximately two months aft...
Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3How to execute dietary management in eating disorder patients 61699 1How to execute dietary management in eating disorder patients 61699 2Elsevier celebrates the 20th anniversary of the UN Convention for the Rights of the Child 61697 1Elsevier celebrates the 20th anniversary of the UN Convention for the Rights of the Child 61697 2The benefits of stress in plants 10805 1The benefits of stress in plants 10805 2
...netic and safety data observed in first clinical ...agent -, CAMBRIDGE, Mass., Oct. 24 Mersana, a ca...ts of a Phase I study of its,lead product candidat...s.,The data was presented by Edward A. Sausville, ...rector for Clinical Research, University of,Maryla...
...imacy and Safety of ,First Generation, Antisense, ...ed (Nasdaq: GNTA ) announced the presentation of ...ium) Injection, its lead anticancer,compound, can ...travenous,(IV) infusion. The new data were present...search, South Texas Accelerated Research Therapeut...
Other Medicine Technology:Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 2Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4
(Date:12/4/2009)...Dec. 4 The National Cancer Institu...ract to Fred Hutchinson Cancer Research Center to ...formation Service Contact Center. ,, The move w...nearly tripling the size of its current CIS workfo...ional, which is scheduled for March 15, 2010. The ...
(Date:12/4/2009)...09 -- Substantial progress has been made over the ...y to diagnose and treat epilepsy and its complicat...s not reached most of the 50 million people around...lion people in the United States who have the diso...president of the American Epilepsy Society (AES), ...
(Date:12/4/2009)... Bobby Berk Home & Author and Political Analy...l Toy Drive benefiting Providence Hospital’s...m. The goal is to raise $5000 in cash and toy dona..., Bobby Berk Home will match the donation. Toys wi...9th at Providence Hospital. , ...
(Date:12/4/2009)...t clear enough to recommend its use, experts say ,... Cancer patients, glaucoma patients and others can...lysis shows that it can help multiple sclerosis (M...t are the hallmark of the debilitating autoimmune ...inoids in MS appears to be comprehensive, and shou...
(Date:12/4/2009)...Y, Calif., Dec. 4 Genomi...at the company will present results from five stud...ymposium (SABCS), taking place December 9-13, 2009...r of the studies analyze Onco type DX®, the ...ns currently use to predict the likelihood of chem...
Breaking Medicine News(10 mins):Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4
... CLEVELAND--A dart-like molecule that sticks to pr...ecked growth of blood vessels, according to resea...Cleveland Clinic Cole Eye Institute. //Uncontrolle...eople over 65 in the United States. Robert Sa...
... Johns Hopkins Kimmel Cancer Center scientists hav...r breast and colon cancers. Their report, publishe...ss,// identifies close to 200 mutated genes, now l...quencing the human genome laid the groundwork for ...
... A gene that has the potential to suppress tumor g...to three separate studies. The gene p16INK4a cause...younger cells.// These older cells seemed to know ...l schools at the University of North Carolina at C...
... A Virginia Tech researcher Stefan Duma has been n...evelopers for his biomechanics innovations.// ...rofessor of mechanical engineering and founding di...editors of Technology Review, a publication of the...
... Two bacterial muscle infections have been found t...emergence of community-acquired methicillin-resist...o researchers in Houston, Texas whose study was pu...d on the skin or in the nose of a quarter to a thi...
... Modern life has risk and uncertainty as a part of...n aeroplanes, a new generation of nuclear power st...belief in the authorities. The government has to d...logic, particularly, when the apparent risk is rel...
Other Medicine News:Health News:Molecule responsible for age associated macular degeneration identified 2Health News:Genome Code Cracked for Breast and Colon Cancers 2Health News:Genome Code Cracked for Breast and Colon Cancers 3Health News:Gene May Regulate Cellular Aging 2Health News:Gene May Regulate Cellular Aging 3Health News:A young scientist recognized for biomechanics innovations 2Health News:A young scientist recognized for biomechanics innovations 3Health News:MRSA Linked with Rise in Bacterial Infections 2Health News:Danger and insecurity in contemporary life 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: